China Longyi Group International (CGYG) Stock Price, News & Analysis

Company Overview

China Longyi Group International Holdings Ltd. operates as a holding company, which through its subsidiaries, Beijing SOD and Chongqing SOD, develops, manufactures, and markets superoxide dismutase (SOD) products. Its products include SOD Lifeblood, which is a mixture of SOD and enzymes as an antioxidant. The company was founded on February 29, 1996 and is headquartered in Beijing, China.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 2,258 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CGYG Stock Analysis - Frequently Asked Questions

How do I buy shares of China Longyi Group International?

Shares of CGYG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of China Longyi Group International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that China Longyi Group International investors own include AVEO Pharmaceuticals (AVEO), Atossa Genetics (ATOS), Arrowhead Pharmaceuticals (ARWR), Arena Pharmaceuticals (ARNA), Aptose Biosciences (APTO), Ampliphi Biosciences (APHB) and Applied DNA Sciences (APDN).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:CGYG
• CIK: 1010566
• Web: www.allsod.com
• Phone: 861088452568
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A